Purple Biotech ( (PPBT) ) has shared an update.
Purple Biotech Ltd. has announced that its Annual General Meeting of Shareholders will be held on April 15, 2025, in Rehovot, Israel. Key agenda items include the re-election of directors, approval of equity-based awards, and an increase in authorized share capital. Shareholders as of March 6, 2025, are entitled to vote, and the meeting will also review the company’s financial statements for 2024. This meeting is significant for stakeholders as it involves decisions on leadership and capital structure, potentially impacting the company’s strategic direction and shareholder value.
More about Purple Biotech
Purple Biotech Ltd. is a company operating in the biotechnology industry, focusing on the development of innovative cancer therapies. The company is based in Rehovot, Israel, and is involved in advancing its pipeline of oncology products to address unmet medical needs.
YTD Price Performance: -37.91%
Average Trading Volume: 952,808
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $7.98M
For an in-depth examination of PPBT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com